UVA TESTING METHODOLOGY: IN VIVO/IN VITRO COMBINATION METHOD SUGGESTED
This article was originally published in The Tan Sheet
Executive Summary
UVA TESTING METHODOLOGY: IN VIVO/IN VITRO COMBINATION METHOD SUGGESTED by Nicholas Lowe, MD, UCLA School of Medicine, as a testing standard to predict the protective effect of LIVA sunscreens. Speaking at a May 12 public workshop sponsored by FDA on UVA testing methods, Lowe advised FDA to "decide on an appropriate in vivo test which will give us performance data in humans [and] will tell us the characteristics of a specific formulation." He recommended that the in vivo test be used in combination with an in vitro test which will supply "accurate spectral absorbance data."
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
People In Brief
Perrigo promotes in pricing, planning
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: